The usefulness of non-human primates in central nervous system safety pharmacology

被引:11
|
作者
Porsolt, Roger D. [1 ]
机构
[1] Porsolt SAS, ZA Glatigne, F-53940 Le Genest St Isle, France
关键词
Biting; Cognition; Delayed matching/non-matching-to-sample; Dystonia Executive function; Extrapyramidal symptoms (EPS); Frustration-aggression; Methods Non-human primates (NHP); Object retrieval; INTRAVENOUS PHARMACOKINETIC PARAMETERS; QUALITATIVE EVALUATION; ALZHEIMERS-DISEASE; OBJECT RETRIEVAL; RHESUS-MONKEYS; ANIMAL-MODELS; DRUGS; RAT; EXTRAPOLATION; PERFORMANCE;
D O I
10.1016/j.vascn.2013.03.004
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: The present paper will suggest, on the basis of experimental evidence, that several non-human primate (NHP) procedures can be uniquely useful and relevant for central nervous system (CNS) safety pharmacology purposes. Methods and results: Classical antipsychotics (e.g. haloperidol) but not atypical antipsychotics (e.g. clozapine), in contrast to rodents, induce behavioral signs in NHP which are clearly homologous to those observed in humans and thus have high translational value. Operant techniques (delayed matching/non-matching-to-sample) and non-operant techniques (object retrieval) can be used in NHP to assess the facilitating and impairing effects of drugs on cognition. Brain structures sub-serving these functions are closer to humans in NHP than in rodents suggesting that drug data from NHP translate better to humans. Biting into a rubber tube can be induced in squirrel monkeys by exposure to non-reinforcement (frustration). This model is close to human notions of frustration/aggression, and is ethically more acceptable than methods using shock or animal fighting. It could therefore serve as a model of drug-induced irritability with potentially high translational value. Conclusion: There are cogent scientific reasons for selecting NHP in CNS and other safety pharmacology areas. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:23 / 29
页数:7
相关论文
共 50 条
  • [31] Infection by Trypanosoma cruzi in the central nervous system in non-human mammals: a systematic review
    Villalba-Aleman, Evaristo
    Sarandy, Mariaurea Matias
    Morais-Santos, Monica
    Novaes, Romulo Dias
    Goncalves, Reggiani Vilela
    PARASITOLOGY, 2019, 146 (08) : 983 - 1005
  • [32] Comprehensive Evaluation of a Barcoded AAV Library in Non-Human Primate Central Nervous System
    Kondratov, O.
    Kondratova, L.
    Mandel, R. J.
    Gamlin, P.
    Bell, R.
    Rabinowitz, J.
    Rodriquez, E.
    Zolotukhin, S.
    MOLECULAR THERAPY, 2020, 28 (04) : 48 - 48
  • [33] Effect of neurosteroid dehydroepiandrosterone on the higher nervous activity of old non-human primates
    Goncharov N.P.
    Katsiya G.V.
    Dzhokua A.A.
    Barkaya V.S.
    Kulava Z.V.
    Mikvabiya Z.Y.
    Human Physiology, 2014, 40 (2) : 149 - 155
  • [34] Safety and efficacy of AAV5-hFIX in non-human primates
    Nijmeijer, Bart
    Petry, Harald
    Spronck, Lisa
    van der Kruijssen, Corina
    Salmon, Florence
    HUMAN GENE THERAPY, 2014, 25 (11) : A38 - A38
  • [35] A pharmacokinetic/pharmacodynamic approach to evaluating the safety of zebularine in non-human primates
    Johnson, William D.
    Harder, J. Brooks
    Naylor, Jennifer
    McCormick, David L.
    Detrisac, Carol J.
    Glaze, Elizabeth R.
    Tomaszewski, Joseph E.
    CANCER RESEARCH, 2006, 66 (08)
  • [36] Immunogenicity of mAbs in non-human primates during nonclinical safety assessment
    van Meer, Peter J. K.
    Kooijman, Marlous
    Brinks, Vera
    Gispen-de Wied, Christine C.
    Silva-Lima, Beatriz
    Moors, Ellen H. M.
    Schellekens, Huub
    MABS, 2013, 5 (05) : 810 - 816
  • [37] The application of electrophysiological methods to characterize AMPA receptors in dissociated adult rat and non-human primate cerebellar neurons for use in neuronal safety pharmacology assessments of the central nervous system
    Miraucourt, Lois S.
    Accardi, Michael V.
    Asin, Karen E.
    Pugsley, Michael K.
    Curtis, Michael J.
    Authier, Simon
    JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2020, 105
  • [38] PHARMACOLOGY OF CENTRAL NERVOUS SYSTEM
    MODELL, W
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1965, 6 (03) : 407 - +
  • [39] PHARMACOLOGY OF CENTRAL NERVOUS SYSTEM
    KLEIN, D
    JOURNAL DE GENETIQUE HUMAINE, 1965, 14 (2-3): : 249 - &
  • [40] PHARMACOLOGY OF CENTRAL NERVOUS SYSTEM
    GREENSTE.JS
    INTERNATIONAL JOURNAL OF FERTILITY, 1965, 10 (04) : 390 - &